White House Details Plan to “Quickly” Vaccinate 28 Million Children Age 5-11

Region:

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

Visit and follow us on Instagram at @crg_globalresearch.

***

 

The Biden administration on Wednesday unveiled its plan to ‘quickly’ vaccinate roughly 28 million children age 5-11, pending authorization from the Food and Drug Administration (FDA).

The jab – which doesn’t prevent transmission of Covid-19 will be available at pediatricians, local pharmacies, and possibly even at schools, according to the White House, which expects FDA authorization of the Pfizer shot for children – the least likely to fall seriously ill or die from the virus, in a matter of weeks, according to the Associated Press.

Federal regulators will meet over the next two weeks to weigh the benefits of giving shots to kids, after lengthy studies meant to ensure the safety of the vaccines.

Within hours of formal approval, expected after the Centers for Disease Control and Prevention advisory meeting scheduled for Nov. 2-3, doses will begin shipping to providers across the country, along with smaller needles necessary for injecting young kids, and within days will be ready to go into the arms of kids on a wide scale. -AP

According to the announcement, the White House has secured enough to supply more than 25,000 doses for pediatricians and primary care physicians who have already signed up to deliver the vaccine, while the country now has enough Pfizer vaccine to jab roughly 28 million kids who will soon be eligible, meaning this won’t be a slow roll-out like we saw 10 months ago when doses and capacity issues meant adults had to wait.

Meanwhile, the White House is rolling out an ‘advertising’ campaign to convince parents and kids that the vaccine is safe and effective. According to the report, “the administration believes trusted messengers — educators, doctors, and community leaders — will be vital to encouraging vaccinations.”

“COVID has also disrupted our kids lives. It’s made school harder, it’s disrupted their ability to see friends and family, it’s made youth sports more challenging,” said surgeon general Dr. Vivek Murthy in a Wednesday statement to NBC. “Getting our kids vaccinated, we have the prospect of protecting them, but also getting all of those activities back that are so important to our children.”

According to Murthy, the administration is leaving the question of mandates for school, local and state officials.

“Those are decisions on, when it comes to school requirements, that are made by localities and by states,” said Murthy. “You’ve seen already some localities and states talk about vaccine requirements for kids. And I think it’s a reasonable thing to consider to get those vaccination rates high. And it’s also consistent with what we’ve done for other childhood vaccines, like measles, mumps, polio.”

The US government has purchased 65 million doses of the Pfizer pediatric shot – which is expected to contain one-third of the dosage for adults and adolescents. The FDA’s independent advisory committee will meet Oct. 26 to consider authorizing the Pfizer shot for children aged 5-11.

To top it all off, CDC Chief Rochelle Walensky says her agency will still recommend that children wear masks in schools even after the vaccine is approved for kids.

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image is from Zero Hedge


Articles by: Zero Hedge

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]